|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Minnesota Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MinnesotaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
ReShape Lifesciences Inc.
| | | Phone: | (651) 634-3003 | Year Established: | 2002 | Ticker: | RSLS | Exchange: | NASDAQ | Main Contact: | Dan Gladney, President, CEO & Chairman | | Other Contacts: | Katherine Tweden Ph.D., VP, Clinical and Regulatory Adrianus (Jos) Donders, Senior VP, Research & Advanced Development Daniel L. Cohen, Senior VP, Government Relations & Health Policy Scott Youngstrom, Senior VP, CFO & Chief Compliance Officer
| | Company Description | ReShape Lifesciences, formerly EnteroMedics® and Beta Medical, is a medical device company focused on technology to treat obesity and metabolic diseases. vBloc® Neurometabolic Therapy, delivered by an FDA-approved pacemaker-like device called the vBloc System, is designed to help patients with a 35-45 Body Mass Index (BMI) feel full and eat less by intermittently blocking hunger signals on the vagus nerve. The FDA-approved ReShape® Integrated Dual Balloon System involves a non-surgical weight loss procedure that uses advanced balloon technology designed to take up room in the stomach to help people with a 30-40 Body BMI, and at least one co-morbidity, lose weight. The Gastric Vest™ System is an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery, and is intended to enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. | |
|
|
|
|
|